The latest news from Asia and the Pacific

Provided by AGP

The Asia Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Asia Reporter.

Press releases published on April 20, 2026

Precedence Research Launches Advanced Cell and Gene Therapy Intelligence Platform to Transform Complex CGT Data into Strategic Decisions
Thermal Imaging Market to Cross $8.78 Billion by 2034 at CAGR of 7.2%: New Research by The Insight Partners
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
Erdene Provides Q1 2026 Bayan Khundii Gold Mine Update
Top Futon Mattress 2026: According to a Sleep Expert
New Found Gold Announces $205M Finance Package
Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD Trial
Toobit Announces $150,000 Event Contracts Campaign with Daily Win Rewards
Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit
Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026
Lahontan to Drill Historic Santa Fe Heap Leach Pads for Residual Gold & Silver
SPARC AI Signs Second Ukrainian Drone Manufacturer, Expanding Distribution Footprint for GPS-Denied Software Platform
Helium Evolution Announces Completion of Grasslands 3D Seismic Program, Board Update and Strengthening Helium Market Outlook
Emerita Announces Board and Management Transitions
Bodor Laser Ranked No. 1 in Global Sales Volume for Seven Consecutive Years, Demonstrating Brand Strength Through Sustained Leadership
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
JETOUR to Unveil “Travel+” Strategy at Auto China 2026
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering

Share us

on your social networks:

Sign up for:

The Asia Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.